Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells.
Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells.
复制标题
DOI:
10.3791/62391
复制
发表时间:
2021-03-31
期刊:
影响因子:
--
通讯作者:
Hirschi KK
中科院分区:
文献类型:
--
作者:
Nelson EA;Qiu J;Chavkin NW;Hirschi KK
Blood vessels are ubiquitously distributed within all tissues of the body and perform diverse functions. Thus, derivation of mature vascular endothelial cells, which line blood vessel lumens, from human pluripotent stem cells is crucial for a multitude of tissue engineering and regeneration applications. In vivo, primordial endothelial cells are derived from the mesodermal lineage and are specified toward specific subtypes, including arterial, venous, capillary, hemogenic and lymphatic. Hemogenic endothelial cells are of particular interest because, during development, they give rise to hematopoietic stem and progenitor cells, which then generate all blood lineages throughout life. Thus, creating a system to generate hemogenic endothelial cells in vitro would provide an opportunity to study endothelial-to-hematopoietic transition, and may lead to ex vivo production of human blood products and reduced reliance on human donors. While several protocols exist for the derivation of progenitor and primordial endothelial cells, generation of well-characterized hemogenic endothelial cells from human stem cells has not been described. Here, a method for the derivation of hemogenic endothelial cells from human embryonic stem cells in approximately one week is presented: a differentiation protocol with primitive streak cells formed in response to GSK3β inhibitor (CHIR99021), then mesoderm lineage induction mediated by bFGF, followed by primordial endothelial cell development promoted by BMP4 and VEGF-A, and finally hemogenic endothelial cell specification induced by retinoic acid. This protocol yields a well-defined population of hemogenic endothelial cells that can be used to further understand their molecular regulation and endothelial-to-hematopoietic transition, which has the potential to be applied to downstream therapeutic applications. Presented here is a simple protocol for the directed differentiation of hemogenic endothelial cells from human pluripotent stem cells in approximately one week.
登录
查看更多内容
DOI:
10.1126/science.1247391
发表时间:
2014-08-22
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Fox IJ;Daley GQ;Goldman SA;Huard J;Kamp TJ;Trucco M
通讯作者:
Trucco M
影响因子:
16.6
作者:
Dejana E;Hirschi KK;Simons M
通讯作者:
Simons M
影响因子:
16.6
作者:
Fang JS;Coon BG;Gillis N;Chen Z;Qiu J;Chittenden TW;Burt JM;Schwartz MA;Hirschi KK
通讯作者:
Hirschi KK
影响因子:
4.6
作者:
Liu, Chun;Oikonomopoulos, Angelos;Wu, Joseph C.
通讯作者:
Wu, Joseph C.
影响因子:
5
作者:
Lee, Hyunjae;Chung, Minhwan;Jeon, Noo Li
通讯作者:
Jeon, Noo Li